Protective strategies to prevent trastuzumab-induced cardiotoxicity - Authors' reply

Affiliations

¹ Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research (NIHR), Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: hme22@cam.ac.uk.
² Warwick Clinical Trials Unit, University of Warwick, Coventry, UK.
³ Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Freeman Hospital, Newcastle upon Tyne, UK.
⁴ Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
⁵ Research and Development, NIHR Manchester Clinical Research Facility, Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
⁶ Cancer Edinburgh Research Centre, The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.

Comment

Helena M Earl et al. Lancet. 2020.

. 2020 Feb 15;395(10223):492-493.

doi: 10.1016/S0140-6736(19)32544-9.

¹ Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research (NIHR), Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: hme22@cam.ac.uk.
² Warwick Clinical Trials Unit, University of Warwick, Coventry, UK.
³ Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Freeman Hospital, Newcastle upon Tyne, UK.
⁴ Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
⁵ Research and Development, NIHR Manchester Clinical Research Facility, Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
⁶ Cancer Edinburgh Research Centre, The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.

No abstract available

Comment on

Protective strategies to prevent trastuzumab-induced cardiotoxicity.
Guo S, Tse G, Liu T. Guo S, et al. Lancet. 2020 Feb 15;395(10223):491-492. doi: 10.1016/S0140-6736(19)32549-8. Lancet. 2020. PMID: 32061289 No abstract available.